These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10499425)

  • 21. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series.
    Ioja E; Tóth G; Benyhe S; Tourwe D; Péter A; Tömböly C; Borsodi A
    Neurosignals; 2005; 14(6):317-28. PubMed ID: 16772734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding characteristics of the novel highly selective delta agonist, [3H]IIe5,6deltorphin II.
    Nevin ST; Kabasakal L; Otvös F; Töth G; Borsodi A
    Neuropeptides; 1994 Apr; 26(4):261-5. PubMed ID: 8028715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.
    Keller M; Boissard C; Patiny L; Chung NN; Lemieux C; Mutter M; Schiller PW
    J Med Chem; 2001 Nov; 44(23):3896-903. PubMed ID: 11689075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
    Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
    J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bifunctional μ/δ opioid peptides: variation of the type and length of the linker connecting the two components.
    Ding J; Lemieux C; Chung NN; Schiller PW
    Chem Biol Drug Des; 2012 Feb; 79(2):186-93. PubMed ID: 22070627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and pharmacological activity of the N-terminal dermorphin tetrapeptide analogs with CH2-NH peptide bond isosteres.
    Salvadori S; Guerrini R; Borea PA; Tomatis R
    Int J Pept Protein Res; 1992 Nov; 40(5):437-44. PubMed ID: 1362392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of morphine tolerance and dependence with the highly selective delta-opioid receptor antagonist TIPP[psi].
    Fundytus ME; Schiller PW; Shapiro M; Weltrowska G; Coderre TJ
    Eur J Pharmacol; 1995 Nov; 286(1):105-8. PubMed ID: 8566146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.
    Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
    J Med Chem; 2004 Jul; 47(16):4066-71. PubMed ID: 15267245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A solid-phase synthetic strategy for labeled peptides: synthesis of a biotinylated derivative of the delta opioid receptor antagonist TIPP (Tyr-Tic-Phe-Phe-OH).
    Kumar V; Aldrich JV
    Org Lett; 2003 Mar; 5(5):613-6. PubMed ID: 12605472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bonds.
    Wilkes BC; Nguyen TM; Weltrowska G; Carpenter KA; Lemieux C; Chung NN; Schiller PW
    J Pept Res; 1998 May; 51(5):386-94. PubMed ID: 9606018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profound spinal tolerance after repeated exposure to a highly selective mu-opioid peptide agonist: role of delta-opioid receptors.
    Zhao GM; Wu D; Soong Y; Shimoyama M; Berezowska I; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2002 Jul; 302(1):188-96. PubMed ID: 12065716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid phase synthesis and evaluation of Tyr-Tic-Phe-Phe(p-NHCOCH(2)Br) ([Phe(p-bromoacetamide)(4)]TIPP), a potent affinity label for delta opioid receptors.
    Kumar V; Murray TF; Aldrich JV
    J Med Chem; 2002 Aug; 45(18):3820-3. PubMed ID: 12190304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aladan3]TIPP: a fluorescent delta-opioid antagonist with high delta-receptor binding affinity and delta selectivity.
    Chen H; Chung NN; Lemieux C; Zelent B; Vanderkooi JM; Gryczynski I; Wilkes BC; Schiller PW
    Biopolymers; 2005; 80(2-3):325-31. PubMed ID: 15614807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
    Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism.
    Salvadori S; Guerrini R; Balboni G; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1999 Dec; 42(24):5010-9. PubMed ID: 10585210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.
    Balboni G; Guerrini R; Salvadori S; Bianchi C; Rizzi D; Bryant SD; Lazarus LH
    J Med Chem; 2002 Jan; 45(3):713-20. PubMed ID: 11806723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
    Charpentier S; Sagan S; Delfour A; Nicolas P
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2.
    Wilkes BC; Schiller PW
    Biopolymers; 1994 Sep; 34(9):1213-9. PubMed ID: 7948733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended TIP(P) analogues as precursors for labeled delta-opioid receptor ligands.
    Kumar V; Murray TF; Aldrich JV
    J Med Chem; 2000 Dec; 43(26):5050-4. PubMed ID: 11150177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.